Recently, relationships between higher FGF-21 levels and adverse lipid profiles, obesity, metabolic syndrome, or type 2 diabetes mellitus have been reported in adults (24). The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.